Synopsys - SNPS Stock Forecast, Price & News

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Atlantic Securities lowered their target price on shares of Synopsys to $350.00 and set a "na" rating on the stock in a research note on Thursday, May 19th. Wells Fargo & Company lowered their target price on shares of Synopsys from $415.00 to $375.00 and set an "overweight" rating on the stock in a research note on Thursday, May 19th. StockNews.com cut shares of Synopsys from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, May 3rd. UBS Group lowered their target price on shares of Synopsys to $360.00 and set a "hold" rating on the stock in a research note on Thursday, May 19th. Finally, Bank of America upgraded shares of Synopsys from an "underperform" rating to a "neutral" rating and increased their price objective for the stock from $325.00 to $360.00 in a research note on Wednesday, June 29th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $381.70.

Synopsys Trading Down 0.6 %

Synopsys stock opened at $372.07 on Tuesday. The firm has a 50 day moving average of $323.00 and a 200 day moving average of $309.65. The firm has a market capitalization of $56.92 billion, a price-to-earnings ratio of 57.86, a P/E/G ratio of 3.04 and a beta of 1.22. Synopsys has a 12-month low of $255.02 and a 12-month high of $378.46.

Synopsys (NASDAQ:SNPS - Get Rating) last released its earnings results on Wednesday, May 18th. The semiconductor company reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.09. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.25 billion. Synopsys had a net margin of 21.19% and a return on equity of 18.23%. During the same period in the prior year, the firm posted $1.24 EPS. On average, analysts predict that Synopsys will post 6.29 EPS for the current year.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider John F. Runkel, Jr. sold 3,463 shares of the stock in a transaction that occurred on Tuesday, June 7th. The shares were sold at an average price of $330.00, for a total transaction of $1,142,790.00. Following the completion of the sale, the insider now directly owns 22,623 shares of the company's stock, valued at approximately $7,465,590. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, COO Sassine Ghazi sold 4,651 shares of the firm's stock in a transaction on Friday, July 1st. The shares were sold at an average price of $300.67, for a total value of $1,398,416.17. Following the completion of the transaction, the chief operating officer now directly owns 45,173 shares of the company's stock, valued at $13,582,165.91. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider John F. Runkel, Jr. sold 3,463 shares of the business's stock in a transaction on Tuesday, June 7th. The stock was sold at an average price of $330.00, for a total transaction of $1,142,790.00. Following the completion of the sale, the insider now owns 22,623 shares in the company, valued at approximately $7,465,590. The disclosure for this sale can be found here. Insiders sold a total of 129,285 shares of company stock valued at $39,219,908 in the last three months. 1.20% of the stock is currently owned by corporate insiders.